Becton Dickinson

85
Becton Dickinson
Becton Dickinson is listed in the Scientific Apparatus & Instruments category in Durham, North Carolina. Displayed below are the social networks for Becton Dickinson which include a Facebook page, a Linkedin company page, a Twitter account and a YouTube channel. The activity and popularity of Becton Dickinson on these social networks gives it a ZapScore of 85.

Contact information for Becton Dickinson is:
1 Becton Cir
Durham, NC 27712
(919) 620-6200

"Becton Dickinson" - Social Networks

Click to visit the social networks of Becton Dickinson:
85
Becton Dickinson has an overall ZapScore of 85. This means that Becton Dickinson has a higher ZapScore than 85% of all businesses on Zappenin. For reference, the median ZapScore for a business in Durham, North Carolina is 40 and in the category is 40. Learn more about ZapScore.

Do you own or manage this business? Click here to claim the Becton Dickinson listing and add social networks, logos, descriptions and more.

Becton Dickinson Contact Information:

Social Posts for Becton Dickinson


Watch @uconnhealth executives, pharmacy and nursing staff share #medsafety benefits of #PyxisES platform twitter.com/i/web/status/8…


Register today! ES System Manager Certificate Program and Pyxis & Alaris Data Workshops! Visit BD Learning Compass bddy.me/2sB8Nwg


RT @HPN_Online: bddy.me/2ssQQji


RT @DOTmedcom: Infusion pump market evolves to keep up with hospital platform technology trends bddy.me/2rAeBch


Pyxis & Alaris customers: visit the new BD Learning Compass! 400 web courses, documents, training guides & videos. bddy.me/2rvQU4K

A part of our continued commitment to pursue our purpose of advancing the world of health, we’re excited to share our 2016 Sustainability Report. Learn more about BD’s sustainability strategy and how we’re already making progress on our 2020 Sustainability goals at http://bddy.me/2qYw8ue. Our Sustainability Report offers a broad view of the company’s role in addressing global societal issues in four strategic areas: (1) Innovation – How we contribute to more sustainable healthcare systems by improving outcomes, reducing system costs and protecting patients and healthcare workers (2) Access – How we support health systems in emerging and developing economies, and how we reach vulnerable populations globally (3) Efficiency – How we work across our value chain to minimize environmental impact and create positive social impact (4) Empowerment – How we advance our purpose-driven culture through workforce and community engagements
An overview of BD's sustainability strategy, covering the areas of innovation, access, efficiency and empowerment.

BD (Becton, Dickinson and Company) added 2 new photos.
The BD Life Sciences – Diagnostic Systems leadership team recently hosted United States Senator Chris Van Hollen at BD’s Sparks, Maryland campus. Senator Van Hollen met with the Sparks team to learn more about the Diagnostic Systems business and took a tour of our high-tech instrument manufacturing plant. Senator Van Hollen also received an exclusive tour of our new Global Services Learning Lab, a state-of-the-art multi-use space designed to give customers and BD associates hands-on training experience.

At BD, we’re committed to providing health care workers with the proper protections required to handle hazardous drugs that can help save the lives of patients in need. It is because of this commitment that we would like to commend Assemblywoman Angelica Jimenez (D-Hudson) for advancing health care worker safety in New Jersey by championing (A-837) “Hazardous Drug Safe Handling Act” into law. http://bddy.me/2qx91nd

Learn more about how BD and Bard will deliver innovative healthcare solutions http://bdandbard.transactionannouncement.com/

Check out company leaders discussing BD’s proposed acquisition of Bard, which will create a highly differentiated medical technology company uniquely focused on delivering innovative healthcare solutions to improve clinical and economic outcomes. https://www.youtube.com/watch?v=8APAEfBojL0
Check out company leaders discussing BD's proposed acquisition of Bard, which will create a highly differentiated medical technology company uniquely focused on delivering innovative healthcare solutions to improve clinical and economic outcomes.